Literature DB >> 27325068

Paraoxonase-1 and Early-Life Environmental Exposures.

Judit Marsillach1, Lucio G Costa2, Clement E Furlong3.   

Abstract

Acute and chronic exposures to widely used organophosphorus (OP) insecticides are common. Children's detoxification mechanisms are not well developed until several years after birth. The increased cases of neurodevelopmental disorders in children, together with their increased susceptibility to OP neurotoxicity cannot be explained by genetic factors alone but could be related to gene-environment interactions. Paraoxonase-1 (PON1) is an enzyme that can detoxify OPs but its catalytic efficiency for hydrolysis to certain OPs is modulated by the Q192R polymorphism. Studies with animals have provided important information on the role of PON1 in protecting against gestational and postnatal toxicity to OPs. The PON1Q192 allele is less efficient in hydrolyzing certain OPs than the PON1R192 allele. Maternal PON1 status (PON1 activity levels, the most important measurement, and functional Q192R phenotype) modulates the detrimental effects of exposure to the OP chlorpyrifos oxon on fetal brain gene expression and biomarkers of exposure. Epidemiologic studies suggest that children from mothers with lower PON1 status who were in contact with OPs during pregnancy tend to show smaller head circumference at birth and adverse effects in cognitive function during childhood. Infants and children are vulnerable to OP toxicity. The detrimental consequences of OPs on neurodevelopment can lead to future generations with permanent cognitive problems and susceptibility to develop neurodegenerative diseases. Improved methods using mass spectrometry to monitor OP-adducted biomarker proteins are needed and will be extremely helpful in early life biomonitoring, while measurement of PON1 status as a biomarker of susceptibility will help identify mothers and children highly sensitive to OPs. The use of adductomics instead of enzymatic activity assays for biomonitoring OP exposures have proved to provide several advantages, including the use of dried blood spots, which would facilitate monitoring newborn babies and children.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  early-life exposures; environmental health; neurodevelopment; organophosphates; paraoxonase-1

Mesh:

Substances:

Year:  2016        PMID: 27325068      PMCID: PMC4916371          DOI: 10.1016/j.aogh.2016.01.009

Source DB:  PubMed          Journal:  Ann Glob Health        ISSN: 2214-9996            Impact factor:   2.462


  54 in total

1.  Serum esterases. I. Two types of esterase (A and B) hydrolysing p-nitrophenyl acetate, propionate and butyrate, and a method for their determination.

Authors:  W N ALDRIDGE
Journal:  Biochem J       Date:  1953-01       Impact factor: 3.857

2.  Expression of human paraoxonase (PON1) during development.

Authors:  Toby B Cole; Rachel L Jampsa; Betsy J Walter; Tara L Arndt; Rebecca J Richter; Diana M Shih; Aaron Tward; Aldons J Lusis; Rhona M Jack; Lucio G Costa; Clement E Furlong
Journal:  Pharmacogenetics       Date:  2003-06

3.  Serum esterases. II. An enzyme hydrolysing diethyl p-nitrophenyl phosphate (E600) and its identity with the A-esterase of mammalian sera.

Authors:  W N ALDRIDGE
Journal:  Biochem J       Date:  1953-01       Impact factor: 3.857

Review 4.  Anticholinesterase toxicity and oxidative stress.

Authors:  Dejan Milatovic; Ramesh C Gupta; Michael Aschner
Journal:  ScientificWorldJournal       Date:  2006-02-28

5.  Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning.

Authors:  Richard C Stevens; Stephanie M Suzuki; Toby B Cole; Sarah S Park; Rebecca J Richter; Clement E Furlong
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-18       Impact factor: 11.205

Review 6.  Review of the toxicology of chlorpyrifos with an emphasis on human exposure and neurodevelopment.

Authors:  David L Eaton; Robert B Daroff; Herman Autrup; James Bridges; Patricia Buffler; Lucio G Costa; Joseph Coyle; Guy McKhann; William C Mobley; Lynn Nadel; Diether Neubert; Rolf Schulte-Hermann; Peter S Spencer
Journal:  Crit Rev Toxicol       Date:  2008       Impact factor: 5.635

7.  Repeated gestational exposure of mice to chlorpyrifos oxon is associated with paraoxonase 1 (PON1) modulated effects in maternal and fetal tissues.

Authors:  Toby B Cole; Wan-Fen Li; Aila L Co; Ariel M Hay; James W MacDonald; Theo K Bammler; Federico M Farin; Lucio G Costa; Clement E Furlong
Journal:  Toxicol Sci       Date:  2014-07-28       Impact factor: 4.849

8.  Chlorpyrifos: pharmacokinetics in human volunteers.

Authors:  R J Nolan; D L Rick; N L Freshour; J H Saunders
Journal:  Toxicol Appl Pharmacol       Date:  1984-03-30       Impact factor: 4.219

9.  PON1 and neurodevelopment in children from the CHAMACOS study exposed to organophosphate pesticides in utero.

Authors:  Brenda Eskenazi; Karen Huen; Amy Marks; Kim G Harley; Asa Bradman; Dana Boyd Barr; Nina Holland
Journal:  Environ Health Perspect       Date:  2010-12       Impact factor: 9.031

10.  Validation of PON1 enzyme activity assays for longitudinal studies.

Authors:  Karen Huen; Rebecca Richter; Clement Furlong; Brenda Eskenazi; Nina Holland
Journal:  Clin Chim Acta       Date:  2008-12-24       Impact factor: 3.786

View more
  9 in total

1.  Effects of Chlorpyrifos or Methyl Parathion on Regional Cholinesterase Activity and Muscarinic Receptor Subtype Binding in Juvenile Rat Brain.

Authors:  Shirley X Guo-Ross; Edward C Meek; Janice E Chambers; Russell L Carr
Journal:  J Toxicol Pharmacol       Date:  2017-12-30

Review 2.  Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development.

Authors:  Carlo Cervellati; Giuseppe Valacchi; Veronica Tisato; Giovanni Zuliani; Judit Marsillach
Journal:  Minerva Med       Date:  2018-10-11       Impact factor: 4.806

Review 3.  Gestational exposures to organophosphorus insecticides: From acute poisoning to developmental neurotoxicity.

Authors:  Spencer W Todd; Eric W Lumsden; Yasco Aracava; Jacek Mamczarz; Edson X Albuquerque; Edna F R Pereira
Journal:  Neuropharmacology       Date:  2020-08-16       Impact factor: 5.250

4.  When enough data are not enough to enact policy: The failure to ban chlorpyrifos.

Authors:  Leonardo Trasande
Journal:  PLoS Biol       Date:  2017-12-21       Impact factor: 8.029

5.  Therapeutic Delivery of Butyrylcholinesterase by Brain-Wide Viral Gene Transfer to Mice.

Authors:  Yang Gao; Liyi Geng; Vicky Ping Chen; Stephen Brimijoin
Journal:  Molecules       Date:  2017-07-08       Impact factor: 4.411

6.  Severe Adverse Reactions Following Ketoconazole, Fluconazole, and Environmental Exposures: A Case Report.

Authors:  Allan Lieberman; Luke Curtis
Journal:  Drug Saf Case Rep       Date:  2018-04-18

7.  Reevaluation of Serum Arylesterase Activity in Neurodevelopmental Disorders.

Authors:  Ignazio Stefano Piras; Stefano Gabriele; Laura Altieri; Federica Lombardi; Roberto Sacco; Carla Lintas; Barbara Manzi; Paolo Curatolo; Maria Nobile; Catia Rigoletto; Massimo Molteni; Antonio M Persico
Journal:  Antioxidants (Basel)       Date:  2021-01-22

8.  Effect of Pro-Environmental Prenatal Education Program on Pregnant Women's Environmental Health Awareness and Behaviors based on the Protection Motivation Theory.

Authors:  Hyun Kyoung Kim; Geum Hee Jeong
Journal:  Inquiry       Date:  2022 Jan-Dec       Impact factor: 1.730

9.  Prenatal Exposure to Organophosphorus Pesticides and Preschool ADHD in the Norwegian Mother, Father and Child Cohort Study.

Authors:  Cherrel K Manley; Gro D Villanger; Cathrine Thomsen; Enrique Cequier; Amrit K Sakhi; Ted Reichborn-Kjennerud; Amy H Herring; Kristin R Øvergaard; Pal Zeiner; Kyle R Roell; Lawrence S Engel; Elizabeth M Kamai; Jake Thistle; Amber Hall; Heidi Aase; Stephanie M Engel
Journal:  Int J Environ Res Public Health       Date:  2022-07-02       Impact factor: 4.614

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.